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Abstract
Dynorphins, endogenous opioid peptides that arise from the precursor protein prodynorphin (Pdyn), are hypothesized to be
involved in the regulation of mood states and the neuroplasticity associated with addiction. The current study tested the
hypothesis that dynorphin in the nucleus accumbens (NAcc) mediates such effects. More specifically, we examined whether
knockdown of Pdyn within the NAcc in rats would alter the expression of depressive-like and anxiety-like behavior, as well as
cocaine locomotor sensitization. Wistar rats were injected with adeno-associated viral (AAV) vectors encoding either a Pdyn-
specific short hairpin RNA (AAV-shPdyn) or a scrambled shRNA (AAV-shScr) as control. Four weeks later, rats were tested for
anxiety-like behavior in the elevated plus maze test and depressive-like behavior in the forced swim test (FST). Finally, rats
received one daily injection of saline or cocaine (20 mg/kg, i.p.), followed by assessment of locomotion for 4 consecutive
days. Following 3 days of abstinence, the rats completed 2 additional daily cocaine/saline locomotor trials. Pdyn knockdown
in the NAcc led to a significant reduction in depressive-like behavior in the FST, but had no effect on anxiety-like behavior in
the elevated plus maze. Pdyn knockdown did not alter baseline locomotor behavior, the locomotor response to acute
cocaine, or the initial sensitization of the locomotor response to cocaine over the first 4 cocaine treatment days. However,
following 3 days abstinence the locomotor response to the cocaine challenge returned to their original levels in the AAV-
shPdyn rats while remaining heightened in the AAV-shScr rats. These results suggest that dynorphin in a very specific area
of the nucleus accumbens contributes to depressive-like states and may be involved in neuroadaptations in the NAcc that
contribute to the development of cocaine addiction as a persistent and lasting condition.
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Introduction
Dynorphins, a class of opioid peptides that arise from the
precursor protein prodynorphin (encoded by the Pdyn gene), have
been implicated in emotional control and stress responses in
general [1], and in the negative emotional states associated with
drug addiction in particular [2]. Dynorphins are the primary
endogenous ligands of kappa opioid receptors (KOR) and systemic
or central KOR activation produces dysphoria in humans [3,4]
and depressive-like behaviors in rodents, including increased
elevated reward thresholds in the intracranial self-stimulation test
(ICSS) [5], and increased immobilization in the forced swim test
(FST) [6]. Conversely, KOR antagonism produces antidepressant-
like effects in the FST and ICSS test in rodents [7–9]. Moreover,
Pdyn knockout (KO) mice have shown reduced stress-induced
depressive-like behavior in the FST [8]. The dynorphin/KOR
system appears to also be involved in anxiety, as systemic
administration of KOR antagonists to rodents dose-dependently
reduces anxiety-like behavior in the elevated plus maze [10,11],
the open field [11], and the fear-potentiated startle paradigm [10].
In contrast, studies making use of Pdyn KO mice showed mixed
results, with some studies demonstrating anxiolytic-like behavior in
the elevated plus maze, and open field test [12], while others
showed increased anxiety-like behavior [13].
Although dynorphin and KORs are abundant throughout the
CNS [14,15], the depressive-like and dysphoric-like effects of
dynorphin in general, and in response to stress in particular, have
been hypothesized to be mediated by interactions with dopami-
nergic and serotonergic systems [16,17]. Dopaminergic cell bodies
are located in the ventral tegmental area (VTA) and project to the
prefrontal cortex (PFC; the mesocortical system) and to the
nucleus accumbens (NAcc, the mesolimbic system). Dopamine
secretion, particularly within the NAcc, is known to be important
for motivation, reward and mood regulation [18,19]. Administra-
tion of the dynorphin A analog E-2078 into the VTA, NAcc or
PFC, induces conditioned place aversion in rats [20], and KOR
activation attenuates dopamine release in the NAcc [21,22], as
well as the mPFC [23]. Indeed, KORs on dopaminergic terminals
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in the PFC mediate the aversive impact of systemic KOR
activation [23], and administration of the KOR agonist U50,488
directly into the NAcc shell increases the reward thresholds in the
ICSS test [24]. Conversely, intra-NAcc delivery of the KOR
antagonist nor-binaltorphimine (norBNI) produces antidepressant-
like effect in rodent models of learned helplessness [25,26]. Thus,
KOR-dependent inhibition of dopamine release in the NAcc likely
plays a central role in dynorphin-mediated dysphoria [18,27]. In
addition, data suggest that serotonergic projections from the dorsal
raphe nucleus (DRN) to the NAcc have a central role in the
regulation of aversive behavioral responses by the dynorphin/
KOR activation [17]. Specifically, KOR activation in the NAcc
induces local increase in serotonin transport, particularly in the
synaptic terminals of DRN neurons, and this neuropharmacolog-
ical action has been hypothesized to contribute to a hyposer-
otonergic state that may contribute to prodepressive effects [28].
Finally, KOR agonists decrease GABA and glutamate levels in the
NAcc [29] and may thus also contribute to the overall reward state
regulation via dynorphin/KOR activation. In contrast, the
contribution of dynorphin/KOR activation in the NAcc to
anxiety-like behavior remains unknown and studies point to the
basolateral amygdala as a region in which KOR activation
mediates anxiety-like behavior [30,31].
The inhibitory effects of dynorphin on dopamine and serotonin
in the NAcc are consistent with growing evidence for the
involvement of the dynorphin/KOR system in drug abuse and
addiction. Specifically, the dynorphin/KOR system has been
strongly implicated in the negative affective states that follow drug
withdrawal and may sustain drug dependence via a process of
negative reinforcement [32–34]. Moreover, dynorphin may be
involved in the process of ‘‘sensitization’’, long-lasting behavioral
and physiological changes that occur as a result of repeated
exposure to psychostimulants (particularly cocaine), and that are
evident in rodents by an increased locomotor response to a cocaine
challenge [35]. The sensitization to the locomotor-enhancing
effects of cocaine largely results from increased dopamineergic
activity, principally in the NAcc [36]. Co-administration of
synthetic KOR agonists and dynorphin with cocaine prevents
the sensitization to the locomotor stimulatory effect of cocaine
[37–39]. However, the delivery of KOR agonists at high
concentrations does not well represent the contribution of
physiological levels of dynorphin. Indeed, a recent study has
shown that the long-lasting KOR antagonist norBNI prevented
the sensitization of the motor response to cocaine [40].
As the specificity of dynorphin to KOR is high but not absolute
[41], a better strategy for exploring the role of NAcc dynorphin in
cocaine sensitization, anxiety and depressive-like behavior, is the
use of genetic approaches. Constitutive deletion of the Pdyn gene
led to mixed results, with one study demonstrating reduced ability
of cocaine to increase NAcc dopamine levels and decreased
cocaine-evoked locomotor activity in Pdyn KO mice [42], and
another study demonstrating enhanced cocaine locomotor sensi-
tization with no difference in the acute effects of cocaine in Pdyn
KO mice [43]. Moreover, Van’t Veer et al. [44] demonstrated that
while constitutive KOR KO mice did not differ from their wild-
type counterparts in anxiety-like behavior and sensitization to the
locomotor-enhancing effects of cocaine, conditional KO mice
lacking KORs in DA-containing neurons showed decreased
anxiety-like behavior and potentiated sensitization. Thus, the
differences between the KO studies may result, at least partially,
from various developmental compensations that complicate
interpretation of results in constitutive gene KO studies. Accord-
ingly, KORs were shown to be up-regulated in Pdyn KO mice
[45]. Furthermore, the KO manipulation in these experiments was
global and conclusions about the specific role of the NAcc could
not be reached.
In the current study we used a genetic approach of greater
temporal and spatial resolution: site-specific Pdyn knockdown of
adult rats using recombinant adeno-associated viral (rAAV)
vectors. This model bypasses the problem of possible develop-
mental compensations for the reduction in prodynorphin produc-
tion and allows for isolation of the NAcc as the site of knockdown.
We injected rAAV vectors expressing a shRNA sequence targeted
at the Pdyn transcript (shPdyn) or a control scrambled shRNA
(shScr) into the NAcc of adult rats and subsequently conducted
behavioral assessments of depressive-like behavior, anxiety-like
behavior and sensitization to the locomotor enhancing effects of
cocaine.
Materials and Methods
Animals
Twenty-two male Wistar rats (250–275 g; Charles River,
Hollister, CA) were group-housed and maintained on a 12 h/12
h light/dark cycle with ad libitum access to food and water, with all
behavioral procedures conducted during the dark phase of the
cycle. All of the animal procedures were conducted in accordance
with the recommendations of the National Institute of Health and
approved by the Scripps Research Institute Institutional Animal
Care and Use Committee (Permit Number: 08-0015). All surgical
procedures were performed under isoflurane anesthesia and all
necessary steps were taken to minimize suffering of the animals.
Viral vectors
Recombinant adeno-associated viral (rAAV) vectors were
produced using an AAV2 helper-free system (Agilent Technolo-
gies), as described in Darcq et al. [46]. The rAAV vectors
expressed a shRNA sequence under the control of mU6 promoter,
along with eGFP under the control of the CMV promoter. The
shRNA sequence targeted at the Pdyn transcript (shPdyn, 59-
GGTTGCTTTGGAAGAAGGCTACA-39) was selected using
BLOCK-iT RNAi designer (Life Technologies, Grand Island,
NY) and reduced expression of a rat prodynorphin-eGFP fusion in
transfected COS-1 cells by 98% compared to a scramble shRNA
sequence with no homology to any transcript (shScr, 59-
GCGCTTAGCTGTAGGATTC-39), as analyzed by fluores-
cence-activated cell sorting (data not shown).
Intracranial viral infusions
Rats were anesthetized (1–3% isoflurane in oxygen mixture) and
placed in a Kopf stereotaxic instrument. Double cannulae (gauge;
Plastics One, Roanoke, VA) were inserted bilaterally above the left
and right NAcc (coordinates relative to bregma: anterior/
posterior, 21.7 mm; medial/lateral, 61.5 mm; dorsal/ventral,
25.8 mm from skull surface) [47[. 2 ml (approximately 5.10*8
physical particles, measured by QPCR using a linearized standard
plasmid) of either the rAAV-shPdyn (N= 12) or the rAAV-shScr
(N= 10) were infused at a rate of 0.25 ml/min using injectors
protruding 2 mm beyond the cannula. Upon completion of the
injection the injectors were left in place for 10 additional minutes
to assure adequate diffusion of the solution. Infusions were
delivered via polyethylene tubing (PE 20) that was connected to a
Hamilton 10 ml syringe.
Experimental design
Behavioral testing began four weeks following the viral-vector
injections, including the elevated plus maze, the forced swim test
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and cocaine-induced locomotor sensitization, according to the
timeline shown in Fig 1.
Elevated plus maze
The elevated plus maze consisted of four arms (50 cm
length610 cm width) elevated 100 cm above the floor. Two of
the arms had 40 cm high dark walls (closed arms), and two had
0.5 cm high ledges (open arms). The arms were angled at 90u to
each other. The apparatus was placed in a quiet room dimmed to
provide 10–20 lux of illumination on the open arms and ,0.5 lux
within the closed arms. The rats were placed in the center of the
maze facing a closed arm and removed after 5 min. The apparatus
was wiped with water and dried between tests.
Forced swim test
The forced swim test (FST) was composed of a 2-day procedure
[48,49]. On the first day (pretest), rats were individually placed in
two clear Plexiglas cylinders (25 cm diameter663 cm height) that
were filled with water (22–24uC, 45 cm depth) for 10 min. The
cylinders were separated from one another by a dark screen. The
water was replaced between subjects. On the second day (test), the
rats were placed in the same condition for 5 min. After each
session, rats were towel dried and returned to their home cage.
Swimming behaviors were videotaped throughout the session. The
dependent measures included immobility (representing ‘‘depres-
sion-like behavior’’), characterized by floating with movements
merely essential to keep the nose above the water, swimming,
which is characterized by horizontal movements across the water
surface, and climbing, which is characterized by vertical move-
ments against walls. These behaviors of the rats were scored using
a time-sampling method in which swimming, climbing or
immobility was rated at a 5 second intervals [48,50].
Cocaine sensitization of locomotor activity
The locomotor activity apparatus consisted of 16 wire mesh
cages (20625636 cm) equipped with 2 horizontal infrared
photobeams situated along the long axis of the cage, 2 cm above
the floor and 16 cm between themselves. During testing, white
noise (70 dB) was present and photocell beam break counts were
recorded, with photocell counts indicative of movement and cage
crossing of movement from one side of the cage to another. Rats
were habituated to the cages for 1 hour per day, for 3 consecutive
days. On the subsequent test days rats were placed in the activity
cages for 1 hour for habituation and recording of baseline
locomotor activity and then half were injected i.p with cocaine
(20 mg/kg/1 ml saline) and half with saline before being placed
back in the activity apparatus cages for 1 additional hour to record
post-treatment behavior. The rats were subjected to 4 consecutive
test days, with each rat receiving the same drug treatment each
day, followed by 3 days of rest and 2 additional test days, to
examine the lasting effects of the repeated cocaine administration
(Fig 1).
In situ hybridization
After completion of all behavioral tests rats were anesthetized
using isoflurane and decapitated. Brains were immediately
harvested, snap-frozen in isopentane and stored at 280uC. Six
series of 20-mm coronal cryostat sections were collected on
Superfrost Plus slides. A first series was processed for in situ
hybridization with a GFP probe to assess location and extent of
viral transduction. A second series was processed for in situ
hybridization with a Pdyn probe to evaluate silencing efficiency
within the transduced area. A plasmid containing the EGFP
sequence subcloned into pGEM-T Easy was donated by Dr.
Richard Rivera (The Scripps Research Institute, La Jolla, CA). A
plasmid containing a 1.7-kb fragment of the rat Pdyn gene
subcloned into pSP64 was obtained from Dr. Joel Elmquist (UT
Southwestern Medical Center, Dallas, TX). Digoxigenin (DIG)-
labeled riboprobes were synthesized using a kit (Roche, Indianap-
olis, IN). Sections were post-fixed in paraformaldehyde (PFA) 4%,
and then acetylated in 0.1 M triethanolamine pH 8.0, acetic acid
0.2%. Following washes in salt sodium citrate (SSC) 2x, sections
were dehydrated and defatted in a graded ethanol/chloroform
series. Pre-hybridization and hybridization were performed at
70uC in a buffer containing 50% formamide, SSC 2x, Ficoll 0.1%,
polyvinylpyrrolidone 0.1%, bovine serum albumin (BSA) 0.1%,
sheared salmon sperm DNA (0.5 mg/mL) and yeast RNA
(0.25 mg/mL). Probes were diluted in the hybridization buffer
(800 ng/mL) and incubated overnight on slides. Post-hybridiza-
tion washes were performed in 50% formamide, SSC 2x, Tween-
20 0.1%. Sections were then blocked for 1 h and incubated with
anti-DIG antibody overnight at 4uC (Roche, 1:2000) in MABT
buffer (0.1 M maleic acid pH 7.5, 0.15 M NaCl, Tween-20 0.1%)
containing 10% normal goat serum (NGS). Following washes in
MABT and incubation in detection buffer (0.1 M Tris-HCl
pH 9.5, 0.1 M NaCl, 0.05 M MgCl2, Tween-20 0.1%), the
reaction with NBT-BCIP was allowed to develop in the dark for
24 h at room temperature. Slides were rinsed, air dried and
mounted in DPX (Sigma, St-Louis, MO). Sections were photo-
graphed using a Zeiss Axiophot microscope equipped with a
QImaging Retiga 2000R color digital camera and QCapture
software at 5x magnification. The anterior commissure was
Figure 1. Experimental design. Rats were administered with either rAAV-shPdyn (N= 12) or the control rAAV-shScr (N= 10) into their nucleus
accumbens (NAcc). 4 weeks later, rats were tested for anxiety-like behavior in the elevated plus maze and then subjected to the forced swim test
(FST), a measure of depressive-like behavior, for 2 consecutive days. Subsequently, the rats were habituated to the locomotor activity apparatus for
1 hour per day, for 3 consecutive days. On the subsequent 4 test days rats were placed in the activity cages for 1 hour recording of baseline
locomotor activity and then half were injected i.p with cocaine (20 mg/kg/1 ml saline) and half with saline before being placed back in the activity
apparatus cages for 1 additional hour to record post-treatment behavior. The rats were subjected to 4 consecutive test days, with each rat receiving
the same drug treatment each day, followed by 3 days of rest and 2 additional test days. Subsequently rats were sacrificed and their brains extracted.
doi:10.1371/journal.pone.0097216.g001
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included in each picture as an anatomical landmark to enable
overlay. Optical density of the hybridization signal was analyzed
using NIH Image J software, with each section corrected for
background, and expressed as arbitrary units.
To estimate the transduction volume (V), the shape of the
transduced region was approximated to an ellipsoid. For each
hemisphere of each rat, the section showing the widest area of
GFP expression was used to measure the area of the cross section
passing through the center of the ellipsoid (A). The GFP signal was
then tracked across coronal sections to estimate the anteroposte-
rior extent of transduction based on section thickness (z). The
transduction volume was computed using the following formula:
V= 2/3*A*z. To calculate silencing efficiency, the section showing
the widest area of GFP expression was overlaid onto the
corresponding serial section processed for Pdyn in situ hybridiza-
tion. The optical density of Pdyn signal within the area of GFP
expression was divided by the measured area to obtain the density
per 1 mm3. These results were then normalized and expressed as a
ratio of control (shScr) levels. For statistical analysis, values
obtained from each hemisphere of each rat were considered as
independent entries.
Data analysis
Results of the FST, elevated plus maze and Pdyn densities were
analyzed using t-test comparisons. Beam breaks in the locomotor
tests were analyzed using area under the curve computation that
was subjected to repeated-measures analysis of variance (ANOVA)
or to one-way ANOVA on single test days. When applicable,
AVOVA was followed by the Newman-Keuls multiple comparison
post hoc test. In all cases, a normality test and equal variance test
were performed before the ANOVA to ensure its validity.
Results
Injection of the rAAV-shRNA vectors into the NAcc produced
a limited transduction volume, as reflected by the density of GFP
(Fig. 2A–E). The volume of the transduced region was
1.1260.094 mm3. The rAAV-shPdyn vector led to a significant
knockdown of Pdyn mRNA expression in the transduced region
compared to the rAAV-shScr vector (79% reduction; t34 = 3.92;
P,0.001; Fig 3).
Anxiety-like behavior was similar between shPdyn and shScr
rats, reflected by a similar amount of time spent in the open arms
of the elevated plus maze (P.0.05; Fig 4). Note that the groups did
not differ also in the time spent in the closed arm entries (P.0.05)
or open arm entries (P.0.05), suggesting that the results were not
affected by differences in locomotion. However, shPdyn rats
demonstrated reduced depression-like behavior in the forced swim
test (FST), as reflected by lower percent of time spent floating
(t19 = 2.74, P,0.01; Fig 5A), and increased percent of time spent
swimming (t19 = 3.94, P,0.01; Fig 5B). Interestingly, climbing
behavior was reduced in the shPdyn rats (t19= 3.07, P,0.01;
Fig 5C). Notably, on the forced-swim pretest, the groups did not
differ in the % of time spent swimming (shPdyn: 76.4162.99%,
shScr: 73.1664.68%, P.0.05), floating (shPdyn: 6.3761.49%,
shScr: 8.462.96%, P.0.05) or climbing (shPdyn: 14.461.95%,
shScr: 16.3964.27%, P.0.05).
A two way ANOVA on the locomotor response to acute
cocaine/vehicle injection (Fig 6A: session 1) revealed a main effect
of Cocaine (f(1,18) = 9.487, P,0.01), and no main effect of Vector
(shPdyn vs, shScr, f(1,18) = 0.041, P.0.05) or a Cocaine6Vector
interaction (f(1,18) = 0.069, P.0.05) suggesting that shPdyn and
shScr rats did not differ in their response to acute cocaine or in
their locomotion in response to saline. However, shPdyn and shScr
rats did differ in their response to repeated cocaine injections. In
particular, while shPdyn and shScr rats showed similar level of
sensitization in their locomotor response to cocaine during the first
4 days of treatment, shPdyn rats demonstrated a significant
reduction in their cocaine-induced locomotion when tested 72h
later (Fig 6A). Specifically, repeated-measures ANOVA revealed a
significant Time6Group interaction (f(15,90) = 2.646, P,0.01).
Accordingly, a one way ANOVA revealed a significant difference
between the AUC data of the study groups on the last 2 test days
(day 5: f(3,18) = 7.64, P,0.01; day 6: f(3,18) = 13.41, P,0.01;
Fig 6B). Subsequent Newman-Keuls post-hoc tests verified that on
both days AUC scores of the cocaine-treated shPdyn rats were
significantly lower than that of the cocaine-treated shScr rats (p,
0.05), and not different from the saline-treated shPdyn rats (P.
0.05).
Discussion
This study was designed to examine the role of dynorphin in the
nucleus accumbens (NAcc) in functions related to mood regulation
and the stimulatory effects of cocaine, as it has been suggested that
dynorphin mediates negative mood states (e.g. depression and
anxiety) and the dependence-related effects of repeated exposure
to cocaine [1,2]. The current study demonstrated that knockdown
of prodynorphin (Pdyn) in the NAcc using a shRNA-encoding
AAV vector has no effect on anxiety-like behavior in the elevated
plus maze but reduces locomotor sensitization following repeated
cocaine administration and leads to significant reduction in
depressive-like behavior in the forced swim test (FST). In the
FST, rats are exposed to water and, following initial engagement
in active escape-related behaviors (swimming and climbing),
demonstrate passive immobile behavior, which is believed to
reflect ‘‘behavioral despair’’ [51]. This procedure has been
criticized as having poor face and construct validities but has
impressive predictive validity, with immobility decreasing in
response to a wide range of antidepressant treatments and
increasing in response to various stressors [52]. One major
concern with the FST is that manipulations that alter motor
activity may give ‘‘false positive/negative’’ effects [51,52].
However, in the current study no differences between the groups
in basal locomotor behavior have been observed in the elevated
plus maze or the locomotor chambers, suggesting that the effects
observed in the FST were depressive-like rather than decreased
locomotor activity.
These findings greatly add to our understanding of the role of
dynorphin expression in the NAcc in regulating mood states and
cocaine locomotor sensitization due to the particular advantages of
the viral vector-mediated knockdown method over more tradi-
tional pharmacological and genetic procedures that were com-
monly used to alter the dynorphin/KOR system. First, KOR
agonists are usually administered acutely in doses which may be
much higher than the relevant physiological levels, and that do not
represent chronic elevation in release. Second, although dynor-
phin-KOR specificity is high, it is not absolute and dynorphins can
bind, for example, also to mu opioid receptors, depending on the
specific dynorphin [41,53]. In addition, the use of traditional
constitutive KO models is usually limited to mice, lacks anatomic
specificity and can be difficult to interpret due to compensatory
developmental changes that may occur in response to the defective
gene.
The NAcc, known to be important for motivation, reward and
addiction, appears to be central for mediating many of the
behavioral effects of dynorphin/KOR activation. KORs are
abundant on dopamine terminals in the NAcc [27], and KOR
Nucleus Accumbens Prodynorphin Knockdown
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activation attenuates dopamine release in the NAcc [21,22], an
effect that is consistent with hypohedonic-like states [54]. Indeed,
intra-NAcc delivery of KOR agonists increased the reward
thresholds in the ICSS test, which is a common animal model of
decreased reward [24], while intra-NAcc delivery of KOR
antagonists induce antidepressive-like effects in the learned
helplessness paradigm [25,26]. Altogether, there is considerable
evidence supporting the role of NAcc dynorphin activation in
mood regulation. The current study substantially adds to these
findings by demonstrating that attenuating dynorphin expression
(rather than KOR activity) in the NAcc substantially diminishes
depressive-like behavior (immobility) in the FST. It is interesting to
note that while shPdyn rats showed reduced immobility and
increased swimming, consistent with antidepressant effect, their
climbing behavior was also reduced. A pattern of increased
swimming, with no change, or even reduction, in climbing is
typical to antidepressants that impact the serotonergic system
[55,56]. This is consistent with reports that suggest that
serotonergic projections from the dorsal raphe nucleus (DRN) to
the NAcc have a central role in the regulation of aversive
behavioral responses by dynorphin/KOR activation [17]. KOR
activation in the NAcc induces local increase in serotonin
transport, and this could contribute to a hyposerotonergic state
that may contribute to prodepressive effects [28]. Thus, the results
Figure 2. In situ hybridization results. In situ hybridization with a GFP probe was conducted to assess location and extent of viral transduction in
rats administered with a rAAV viral vector expressing a shRNA sequence directed at Pdyn transcript(shPdyn) or a control scramble sequence (shScr)
into their nucleus accumbens (NAcc). Figures A (shPdyn rat) and B (shScr rat) portray the typical limited transduction volume within the NAcc
observed in all subjects. In situ hybridization with a Pdyn probe demonstrated substantial reduction of Pdyn mRNA expression in the transduced
region of the shPdyn rats (C) compared to the shScr rats (D). The locations of the rAAV injection sites in each rat are depicted in panel E. Solid black
circles: shPdyn rats; white circles: shScr rats.
doi:10.1371/journal.pone.0097216.g002
Figure 3. Efficacy of prodynorphin (Pdyn) knockdown proce-
dure. The optical density of Pdyn signal within the area of GFP
expression was divided by the measured area to obtain the density per
1 mm3. The viral vector expressing a shRNA sequence directed at Pdyn
transcript (shPdyn) led to a significant reduction of Pdyn mRNA
expression in the transduced region compared to the control shScr
vector. N = 5–6, *p,0.001.
doi:10.1371/journal.pone.0097216.g003
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of the current study may, at least partially, reflect prevention of
this hyposerotenergic state.
It is important to note that our results by themselves do not
necessarily mean that dynorphin produced in the NAcc mediates
depression-like behavior via activating KORs that are local to the
NAcc. Dynorphin-positive neurons in the NAcc do project to
neighboring neurons in this area, including other dynorphin-
positive cells [57] and intra-NAcc administration of a KOR
antagonist is sufficient to induce an antidepressant-like effect in the
learned helplessness paradigm [26]. Dynorphin-positive cells in the
NAcc also project to other brain regions, including the VTA,
substantia nigra (SN) and the ventral pallidum [58]. However,
while the VTA and SN have relatively high levels of KOR mRNA,
their levels of KOR peptide is low and the administration of KOR
agonists into the SN and VTA does not induce conditioned place
aversion [20] and reduced dopamine levels in the NAcc [59],
respectively. Thus, it has been suggested that KORs are produced
in the VTA and SN and subsequently transported to the NAcc,
where they are expressed on presynaptic terminals [60–62].
Therefore, it is likely that down-regulation of prodynorphin in the
NAcc induces depressive-like behavior mainly via activation of
receptors within the NAcc itself. Future studies will verify this
postulation.
In contrast to their role in depressive-like behavior, dynorphin
expression in the NAcc does not seem to be involved in anxiety-
like behavior. In fact, studies have pointed instead to elements of
the amygdala, such as the central nucleus of the amygdala [63]
and the basolateral amygdala [30,31], as regions in which
disruption of KOR attenuates anxiety-like behavior, possibly
through dysregulation in GABA transmission [63].
Several studies have demonstrated that similarly to the effects of
chronic stress [54], repeated exposure to cocaine leads to
upregulation of dynorphin in the NAcc [64]. Thus, it has been
suggested that dynorphin upregulation mediates the negative
emotional effects of cocaine withdrawal, such as hypohedonia [2].
This upregulation may also influence the long-term state resulting
from repeated cocaine exposure that is known as ‘‘sensitization’’
and that is thought to contribute to the development of addiction
[65]. In rodents, the sensitized state includes increase in the
reinforcing and incentive effects of cocaine [66], as well as
augmented locomotor response to a cocaine challenge [35]. A
large body of evidence suggests that cocaine behavioral sensitiza-
tion results from increased mesolimbic dopaminergic activity [67].
Given the modulatory effect of KOR activation on dopamine
release in the NAcc (see above), the dynorphin/KOR system could
play a role in cocaine sensitization. However, manipulations of the
dynorphin/KOR system have yielded inconsistent and even
paradoxical results. Specifically, systemic co-administration of
KOR agonists and cocaine attenuated the development of
sensitization to the locomotor stimulatory effect of cocaine
Figure 4. Prodynorphin (Pdyn) knockdown in the NAcc does not alter anxiety-like behavior. A) Time in the open arms of the elevated
plus maze, a measure of anxiety-like behavior. B) Time in the closed arms of the elevated plus maze. The Groups did not differ in the number of
entries into the open arms (C) or the closed arms (D) of the elevated plus maze, suggesting that the results were not affected by differences in
locomotor activity. N = 10.
doi:10.1371/journal.pone.0097216.g004
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[37–39]. However, the long-lasting KOR antagonist norBNI also
prevented the cocaine locomotor sensitization without affecting
the acute response to cocaine [40]. The results of the current study
demonstrate that Pdyn knockdown in the NAcc did not alter
baseline locomotor behavior or the locomotor response to acute
cocaine, but inhibited sensitization with repeated administrations.
Thus, sensitization developed similarly in shPdyn and shScr rats
on the first 4 cocaine treatment days but after three days of
abstinence the locomotor response to the cocaine challenge
returned to their original levels in the shPdyn rats while remaining
heightened in the shScr group.
This pattern of results suggests that dynorphin in the NAcc plays
less of a role in the development of cocaine sensitization, but more
of a role in supporting the maintenance of the sensitized state.
Thus, dynorphin may be particularly essential for the induction of
cocaine-induced neuroplastic adaptations in the mesolimbic
system that may account for the development of cocaine addiction
as a persistent and lasting pathological condition. To this end, one
can hypothesize that acute dynorphin-induced suppression of
dopamine release decreases the induction of locomotor sensitiza-
tion but chronic reduction in dynorphin modifies compensatory
mechanisms that contribute to expression of sensitization. Alter-
natively, the fact that both Pdyn knockdown and KOR agonists
interfere with cocaine sensitization may suggest that specific
patterns of dopamine release (or another consequence of
dynorphin/KOR activation) determine the long-term effects of
cocaine, and that deviation from these patterns, whether an
increase or a decrease of activity, will disrupt the development or
maintenance of cocaine sensitization.
One limitation of the current study is that the volume of the
NAcc in which Pdyn was silenced was rather small, due to the
limited spread of our AAV2 vectors. It bears noting, however, that
this sub region of the nucleus accumbens (dorsal shore of the core
and shell) is one of the subregions of the NAcc with the highest
immunoreactivity for dynorphin [68]. Nevertheless, although this
restricted knockdown was sufficient to induce significant behav-
ioral effects, we cannot rule out that differences between the
groups in the elevated plus maze would have emerged had a more
extended part of the NAcc been affected by the viral vector. This
possibility will be addressed in future studies using a different AAV
serotype to increase the transduction volume. In addition, future
studies will measure levels of the prodynorphin peptide in order to
Figure 5. Prodynorphin (Pdyn) knockdown in the NAcc attenuated depression-like behavior. A) % of the time in the forced swim test
spent floating, a measure of depressive-like behavior. B) % of the time in the forced swim test spent swimming. C) % of the time in the forced swim
test spent climbing. N= 10, *p,0.01.
doi:10.1371/journal.pone.0097216.g005
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locate brain regions in which dynorphin release may be reduced
following Pdyn knockdown in the NAcc. Finally, prodynorphin is
the precursor protein for several peptides, including dynorphin A,
dynorphin B, and a/b-neo-endorphin [1]. The particular role of
each of these in mood regulation and the effects of cocaine still
remains to be determined.
In summary, the current study demonstrated that AAV-
mediated Pdyn knockdown in the NAcc attenuates depressive-like
behavior, without affecting anxiety-like behavior, and led to the
normalization of the locomotor response to cocaine challenge
subsequent to the development of cocaine sensitization. These
results support the notion that dynorphin plays an important role
in the regulation of mood states and the lasting neuroplastic
consequences of repeated cocaine exposure that may be at the
core of cocaine addiction.
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